US judge won't block Eli Lilly ads for weight-loss drugs, rules against Novo Nordisk

2

By Jonathan Stempel Oct 26 (Reuters) – A US judge on Monday rejected Novo Nordisk's request to block Eli Lilly from continuing weight-loss drug advertisements that the Danish drugmaker considered

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)